{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:06:14Z","timestamp":1791597974144,"version":"4.3.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ebm-journal.org"],"crossmark-restriction":true},"short-container-title":["Exp. Biol. Med."],"abstract":"<jats:p>Ceramides and other sphingolipids are associated with diabetes risk. Here, we examined the association of plasma sphingolipids with insulin sensitivity and secretion in people without diabetes. We enrolled adults without diabetes based on 75-g oral glucose tolerance test. Assessments included clinical examination, insulin sensitivity (hyperinsulinemic euglycemic clamp), and insulin secretion (intravenous glucose tolerance test). Plasma levels of 58 sphingolipid species (including ceramides, monohexosylceramides, sphingomyelins, and sphingosine) were assayed using liquid chromatography tandem mass spectrometry. The study participants (N = 240; 129 Black, 111 White) had a mean age of 43.1 \u00b1 12.0\u00a0y, body mass index (BMI) 29.4 \u00b1 6.23\u00a0kg\/m<jats:sup>2<\/jats:sup>, fasting plasma glucose 91.4 \u00b1 6.91\u00a0mg\/dL, and 2-h plasma glucose 123 \u00b1 26.3\u00a0mg\/dL. Several of the 58 SPLs species assayed showed variable associations with insulin sensitivity (r = 0.17\u20130.35, P = 0.039 - &amp;lt;0.0001) and secretion (r = 0.14\u20130.27; P = 0.038 - &amp;lt;0.0001). After correction for multiple testing, plasma levels of very-long-chain (VLC) monohexosylceramide C34:0 (r = 0.31 \u2013 0.43, P &amp;lt; 0.0001) and VLC sphingomyelins C28-C34 (r = 0.31\u20130.35, P = 0.0004 - &amp;lt;0.0001) were significantly associated with insulin sensitivity. Plasma VLC sphingomyelin level were inversely associated with insulin secretion, plasma glucose, BMI, and waist circumference. We conclude that circulating VLC sphingomyelins are associated positively with insulin action and inversely with insulin secretion and adiposity in normoglycemic adults, indicating a possible link to glucoregulation that precedes the development of dysglycemia.<\/jats:p>","DOI":"10.3389\/ebm.2025.10538","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:10:17Z","timestamp":1750741817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Selective association of plasma sphingolipid species with insulin sensitivity and secretion in normoglycemic Black and White American adults"],"prefix":"10.3389","volume":"250","author":[{"given":"Peace","family":"Asuzu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser Aliye","family":"Feto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frankie","family":"Stentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawajes","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Dagogo-Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1194\/jlr.r800080-jlr200","article-title":"Bioactive sphingolipids: metabolism and function","volume":"50","author":"Bartke","year":"2009","journal-title":"J Lipid Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12017-010-8132-8","article-title":"An introduction to sphingolipid metabolism and analysis by new technologies","volume":"12","author":"Chen","year":"2010","journal-title":"NeuroMolecular Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/s0014-5793(97)00320-7","article-title":"Molecular diversity of sphingolipid signalling","volume":"410","author":"Meyer zu Heringdorf","year":"1997","journal-title":"FEBS Lett"},{"key":"B4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides - lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol and Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41574-020-0320-5","article-title":"The role of ceramides in metabolic disorders: when size and localization matters","volume":"16","author":"Turpin-Nolan","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1506971","DOI":"10.3389\/fendo.2024.1506971","article-title":"Editorial: the role of sphingolipid metabolism in endocrine diseases","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fendo.2019.00577","article-title":"The role of ceramides in insulin resistance","volume":"10","author":"Sokolowska","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100270","DOI":"10.1016\/j.jlr.2022.100270","article-title":"Serum dihydroceramides correlate with insulin sensitivity in humans and decrease insulin sensitivity in vitro","volume":"63","author":"Zarini","year":"2022","journal-title":"J Lipid Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"107734","DOI":"10.1016\/j.jdiacomp.2020.107734","article-title":"Role of ceramides in the pathogenesis of diabetes mellitus and its complications","volume":"35","author":"Mandal","year":"2021","journal-title":"J Diabetes its Complications"},{"key":"B11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1003451","DOI":"10.1371\/journal.pmed.1003451","article-title":"Associations among circulating sphingolipids, \u03b2-cell function, and risk of developing type 2 diabetes: a population-based cohort study in China","volume":"17","author":"Yun","year":"2020","journal-title":"Plos Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e126925","DOI":"10.1172\/jci.insight.126925","article-title":"Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence","volume":"5","author":"Chew","year":"2019","journal-title":"JCI Insight"},{"key":"B14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/ajcn\/nqaa114","article-title":"Serum sphingolipids and incident diabetes in a US population with high diabetes burden: the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL)","volume":"112","author":"Chen","year":"2020","journal-title":"The Am J Clin Nutr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1210\/clinem\/dgae179","article-title":"Plasma ceramides and other sphingolipids in relation to incident prediabetes in a longitudinal biracial cohort","volume":"109","author":"Dagogo-Jack","year":"2024","journal-title":"The J Clin Endocrinol and Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"108699","DOI":"10.1016\/j.diabres.2021.108699","article-title":"Targeted lipidomics reveals associations between serum sphingolipids and insulin sensitivity measured by the hyperinsulinemic-euglycemic clamp","volume":"173","author":"Ye","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/db17-1449","article-title":"Circulating sphingolipids, insulin, HOMA-IR, and HOMA-B: the strong heart family study","volume":"67","author":"Lemaitre","year":"2018","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"E398","DOI":"10.1152\/ajpendo.00134.2015","article-title":"Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans","volume":"309","author":"Bergman","year":"2015","journal-title":"Am J Physiology-Endocrinology Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"16740","DOI":"10.1038\/s41598-022-20243-2","article-title":"Regulation of serine palmitoyl-transferase and Rac1\u2013Nox2 signaling in diabetic retinopathy","volume":"12","author":"Alka","year":"2022","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00018-021-04049-5","article-title":"Activation of neutral sphingomyelinase 2 through hyperglycemia contributes to endothelial apoptosis via vesicle-bound intercellular transfer of ceramides","volume":"79","author":"Zietzer","year":"2021","journal-title":"Cell Mol Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4093\/dmj.2015.39.5.353","article-title":"Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia","volume":"39","author":"Parhofer","year":"2015","journal-title":"Diabetes Metab J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"B23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-4757-1850-8_9","article-title":"Pathophysiology of insulin secretion in diabetes mellitus","volume":"189","author":"Ward","year":"1985","journal-title":"Adv Exp Med Biol"},{"key":"B24","first-page":"33","article-title":"Pathobiology of prediabetes in a biracial cohort (POP-ABC): design and methods","volume":"21","author":"Dagogo-Jack","year":"2011","journal-title":"Ethn Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1210\/jc.2012-2902","article-title":"Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) study: baseline characteristics of enrolled subjects","volume":"98","author":"Dagogo-Jack","year":"2013","journal-title":"The J Clin Endocrinol and Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.1979.237.3.e214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiology-Endocrinology Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/bf00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/jci7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and \u03b2-cell function in human subjects. Evidence for a hyperbolic function","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1194\/jlr.d800051-jlr200","article-title":"Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers","volume":"50","author":"Shaner","year":"2009","journal-title":"J Lipid Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jdiacomp.2018.12.005","article-title":"Analysis of sphingolipid composition in human vitreous from control and diabetic individuals","volume":"33","author":"Wilmott","year":"2019","journal-title":"J Diabetes its Complications"},{"key":"B32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fendo.2018.00172","article-title":"Changes in serum sphingomyelin after Roux-en-Y gastric bypass surgery are related to diabetes status","volume":"9","author":"Carlsson","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1210\/clinem\/dgad595","article-title":"Plasma sphingolipid profile of healthy Black and white adults differs based on their parental history of type 2 diabetes","volume":"109","author":"Mandal","year":"2024","journal-title":"The J Clin Endocrinol and Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1194\/jlr.r005025","article-title":"Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein","volume":"51","author":"Agbaga","year":"2010","journal-title":"J Lipid Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2337\/db17-1034","article-title":"ELOVL4-mediated production of very long-chain ceramides stabilizes tight junctions and prevents diabetes-induced retinal vascular permeability","volume":"67","author":"Kady","year":"2018","journal-title":"Diabetes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.3390\/cells11193082","article-title":"A comprehensive profiling of cellular sphingolipids in mammalian endothelial and microglial cells cultured in normal and high-glucose conditions","volume":"11","author":"Mondal","year":"2022","journal-title":"Cells"},{"key":"B38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.preteyeres.2018.10.004","article-title":"ELOVL4: very long-chain fatty acids serve an eclectic role in mammalian health and function","volume":"69","author":"Hopiavuori","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fncel.2019.00428","article-title":"Novel cellular functions of very long chain-fatty acids: insight from ELOVL4 mutations","volume":"13","author":"De\u00e1k","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.bbalip.2016.08.016","article-title":"Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: a beneficial role for very long-chain sphingolipid species","volume":"1861","author":"Montgomery","year":"2016","journal-title":"Biochim Biophys Acta (Bba) - Mol Cell Biol Lipids"},{"key":"B41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/hep.26015","article-title":"Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes","volume":"57","author":"Park","year":"2013","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.biocel.2011.12.019","article-title":"Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth","volume":"44","author":"Hartmann","year":"2012","journal-title":"The Int J Biochem and Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2337\/db21-0640","article-title":"Very-long-chain unsaturated sphingolipids mediate oleate-induced rat \u03b2-cell proliferation","volume":"71","author":"Castell","year":"2022","journal-title":"Diabetes"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1194\/jlr.m009449","article-title":"Lipidomics reveals a remarkable diversity of lipids in human plasma","volume":"51","author":"Quehenberger","year":"2010","journal-title":"J Lipid Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1126\/science.aav3722","article-title":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science"}],"container-title":["Experimental Biology and Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10538\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:10:18Z","timestamp":1750741818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10538\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":45,"alternative-id":["10.3389\/ebm.2025.10538"],"URL":"https:\/\/doi.org\/10.3389\/ebm.2025.10538","relation":{},"ISSN":["1535-3699"],"issn-type":[{"value":"1535-3699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"10538"}}